Gd-EOB-DTPA-enhanced 3.0 T MR imaging: Quantitative and qualitative comparison of hepatocyte-phase images obtained 10 min and 20 min after injection for the detection of liver metastases from colorectal carcinoma

European Radiology

Volumn 21, Issue 11, 2011, Pages 2336-2343

  Sofue, Keitaro ^a   Tsurusaki, Masakatsu ^a,b   Tokue, Hiroyuki ^a   Arai, Yasuaki ^a   Sugimura, Kazuro ^c  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b SHIMANE UNIVERSITY   (Japan)

^c KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Colorectal carcinoma; Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid; Hepatic metastasis; Hepatocyte phase images; Magnetic resonance imaging

Indexed keywords

GADOXETIC ACID;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE QUALITY; LIVER METASTASIS; LIVER PARENCHYMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITATIVE DIAGNOSIS; QUANTITATIVE DIAGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY ANALYSIS;

ADULT; AGED; COLORECTAL NEOPLASMS; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HEPATOCYTES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; NEOPLASM METASTASIS; PREDICTIVE VALUE OF TESTS; RADIOLOGY; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 80053925376     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-011-2197-0     Document Type: Article

References (23)

1. B Hamm T Staks A Muhler, et al. 1995 Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging Radiology 195 785 792 7754011 1:STN:280:DyaK2M3ntlGrsg%3D%3D
2. TJ Vogl S Kummel R Hammerstingl, et al. 1996 Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA Radiology 200 59 67 8657946 1:STN:280:DyaK283lslWnsw%3D%3D
3. P Reimer EJ Rummeny S Ket, et al. 1996 Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence Radiology 199 177 183 8633143 1:STN:280:DyaK283gtFyqug%3D%3D
4. A Huppertz S Haraida A Kraus, et al. 2005 Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT-initial observations Radiology 234 468 478 15591431 10.1148/radiol.2342040278
5. DA Bluemke D Sahani M Amendola, et al. 2005 Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study Radiology 237 89 98 16126918 10.1148/radiol.2371031842
6. P Reimer EJ Rummeny HE Daldrup, et al. 1997 Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging Eur Radiol 7 275 280 9038130 10.1007/s003300050150 1:STN:280:DyaK2s7ptVektw%3D%3D
7. W Stern F Schick AF Kopp, et al. 2000 Dynamic MR imaging of liver metastases with Gd-EOB-DTPA Acta Radiol 41 255 262 10866081 10.1080/ 028418500127345208 1:STN:280:DC%2BD3czit1Cmsg%3D%3D
8. J Ward 2006 New MR techniques for the detection of liver metastases Cancer Imaging 6 33 42 16766267 10.1102/1470-7330.2006.0007 1:STN:280: DC%2BD28zltFelsg%3D%3D
9. CJ Zech KA Herrmann MF Reiser SO Schoenberg 2007 MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA Magn Reson Med Sci 6 43 52 17510541 10.2463/mrms.6.43
10. R Hammerstingl A Huppertz J Breuer, et al. 2008 Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions Eur Radiol 18 457 467 18058107 10.1007/s00330-007-0716-9
11. CJ Zech L Grazioli J Breuer MF Reiser SO Schoenberg 2008 Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial Invest Radiol 43 504 511 18580333 10.1097/RLI. 0b013e3181705cd1
12. U Motosugi T Ichikawa L Tominaga, et al. 2009 Delay before the hepatocyte phase of Gd-EOB-DTPA-enhanced MR imaging: is it possible to shorten the examination time? Eur Radiol 19 2623 2629 19471935 10.1007/s00330-009-1467-6
13. SM Hussain PA Wielopolski DR Martin 2005 Abdominal magnetic resonance imaging at 3.0 T: problem or a promise for the future? Top Magn Reson Imaging 16 325 335 16785848 10.1097/01.rmr.0000224689.06501.16
14. EM Merkle BM Dale 2006 Abdominal MRI at 3.0 T: the basics revisited AJR Am J Roentgenol 186 1524 1532 16714640 10.2214/AJR.05.0932
15. FM Akisik K Sandrasegaran AM Aisen C Lin C Lall 2007 Abdominal MR imaging at 3.0 T Radiographics 27 1433 1444 17848701 10.1148/rg.275075023
16. JY Choi MJ Kim YE Chung, et al. 2008 Abdominal applications of 3.0-T MR imaging: comparative review versus a 1.5-T system Radiographics 28 30 10.1148/rg.e30
17. M Tsurusaki RC Semelka M Zapparoli, et al. 2008 Quantitative and qualitative comparison of 3.0 T and 1.5 T MR imaging of the liver in patients with diffuse parenchymal liver disease Eur J Radiol 72 314 320 18789840 10.1016/j.ejrad.2008.07.027
18. M Ramalho V Herédia M Tsurusaki E Altun RC Semelka 2009 Quantitative and qualitative comparison of 1.5 and 3.0 Tesla MRI in patients with chronic liver diseases J Magn Reson Imaging 29 869 879 19306415 10.1002/jmri.21719
19. Y Yamashita I Ogata J Urata, et al. 1997 Cavenous hemangioma of the liver; pathologic correlation with dynamic CT findings Radiology 203 121 125 9122378 1:STN:280:DyaK2s3jt1Cisg%3D%3D
20. S Goshima M Kanematsu H Watanabe, et al. 2010 Hepatic hemangioma and metastasis; differentiation with gadoxetate disodium-enhanced MRI with 3 T system AJR Am J Roentogenol 195 941 946 10.2214/AJR.09.3730
21. RC Semelka SM Hussain HB Marcos JT Woosley 2000 Perilesional enhancement of hepatic metastases: correlation between MR imaging and histopathologic findings - initial observations Radiology 215 89 94 10751472 1:STN:280:DC%2BD3c3hslWktA%3D%3D
22. K Nasu Y Kuroki S Nawano, et al. 2006 Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging Radiology 239 122 130 16493012 10.1148/radiol.2383041384
23. K Shimada H Isoda Y Hirokawa, et al. 2010 Comparison of gadolinium-EOB-DTPA-enhanced and diffusion-weighted liver MRI for detection of small hepatic metastases Eur Radiol 20 2690 2698 20563726 10.1007/s00330-010- 1842-3